Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maximilian Lennartz

Showing results (71-80 of 113) with videos related to

Pageof 12
Sort By:
Biomedicines|April 30, 2021
Mesothelin Expression in Human Tumors: A Tissue Microarray Study on 12,679 TumorsSören Weidemann, Pauline Gagelmann, Natalia Gorbokon, et al.
Cancers|December 17, 2024
Carcinoembryonic Antigen Expression in Human Tumors: A Tissue Microarray Study on 13,725 TumorsKristina Jansen, Lara Kornfeld, Maximilian Lennartz, et al.
BJUI Compass|November 14, 2024
Reduced p63 expression is linked to unfavourable prognosis in muscle-invasive urothelial carcinoma of the bladderKira Furlano, Henning Plage, Sebastian Hofbauer, et al.
BMC Cancer|July 3, 2024
KLK7 expression in human tumors: a tissue microarray study on 13,447 tumorsSimon Kind, Carolina Palacios Castillo, Ria Schlichter, et al.
Pathology Oncology Research : POR|July 18, 2020
Secreted Frizzled-Related Protein 4 (SFRP4) Is an Independent Prognostic Marker in Prostate Cancers Lacking TMPRSS2: ERG FusionsChristian Bernreuther, Ferdous Daghigh, Katharina Möller, et al.
Molecular Cancer Research : MCR|March 28, 2023
BLEACH&STAIN 15-marker Multiplexed Imaging in 3,098 Human Carcinomas Reveals Six Major PD-L1-driven Immune Phenotypes with Distinct Spatial OrchestrationElena Bady, Katharina Möller, Tim Mandelkow, et al.
Acta Oncologica (Stockholm, Sweden)|December 2, 2025
L1CAM/CD171 expression in human tumors and its association with tumor phenotypeSeyma Büyücek, Magalie Lurati, Katharina Möller, et al.
Molecular Medicine (Cambridge, Mass.)|June 29, 2026
Prevalence of heterozygous and homozygous 9p21 deletions in human cancer: a tissue microarray study on 4,999 tumors from 125 different tumor typesNatalia Gorbokon, Katharina Teljuk, Nina Schraps, et al.
Virchows Archiv : an International Journal of Pathology|February 17, 2026
Prevalence of KDM6A deficiency in human cancer: A tissue microarray study on 18,570 cancers from 153 different tumor typesFlorian Viehweger, Paul Wirth, Natalia Gorbokon, et al.
BMC Cancer|December 6, 2018
Expression of the immune checkpoint receptor TIGIT in Hodgkin's lymphomaWenchao Li, Niclas C Blessin, Ronald Simon, et al.
Pageof 12

Showing results (71-80 of 113) with videos related to

Sort By:
Pageof 12
Biomedicines|April 30, 2021
Mesothelin Expression in Human Tumors: A Tissue Microarray Study on 12,679 TumorsSören Weidemann, Pauline Gagelmann, Natalia Gorbokon, et al.
Cancers|December 17, 2024
Carcinoembryonic Antigen Expression in Human Tumors: A Tissue Microarray Study on 13,725 TumorsKristina Jansen, Lara Kornfeld, Maximilian Lennartz, et al.
BJUI Compass|November 14, 2024
Reduced p63 expression is linked to unfavourable prognosis in muscle-invasive urothelial carcinoma of the bladderKira Furlano, Henning Plage, Sebastian Hofbauer, et al.
BMC Cancer|July 3, 2024
KLK7 expression in human tumors: a tissue microarray study on 13,447 tumorsSimon Kind, Carolina Palacios Castillo, Ria Schlichter, et al.
Pathology Oncology Research : POR|July 18, 2020
Secreted Frizzled-Related Protein 4 (SFRP4) Is an Independent Prognostic Marker in Prostate Cancers Lacking TMPRSS2: ERG FusionsChristian Bernreuther, Ferdous Daghigh, Katharina Möller, et al.
Molecular Cancer Research : MCR|March 28, 2023
BLEACH&STAIN 15-marker Multiplexed Imaging in 3,098 Human Carcinomas Reveals Six Major PD-L1-driven Immune Phenotypes with Distinct Spatial OrchestrationElena Bady, Katharina Möller, Tim Mandelkow, et al.
Acta Oncologica (Stockholm, Sweden)|December 2, 2025
L1CAM/CD171 expression in human tumors and its association with tumor phenotypeSeyma Büyücek, Magalie Lurati, Katharina Möller, et al.
Molecular Medicine (Cambridge, Mass.)|June 29, 2026
Prevalence of heterozygous and homozygous 9p21 deletions in human cancer: a tissue microarray study on 4,999 tumors from 125 different tumor typesNatalia Gorbokon, Katharina Teljuk, Nina Schraps, et al.
Virchows Archiv : an International Journal of Pathology|February 17, 2026
Prevalence of KDM6A deficiency in human cancer: A tissue microarray study on 18,570 cancers from 153 different tumor typesFlorian Viehweger, Paul Wirth, Natalia Gorbokon, et al.
BMC Cancer|December 6, 2018
Expression of the immune checkpoint receptor TIGIT in Hodgkin's lymphomaWenchao Li, Niclas C Blessin, Ronald Simon, et al.
Pageof 12